177-Lu SNA 017
Alternative Names: 177-Lu SNA 017 - SmartNuclide Biopharma; SNA-017 - SmartNuclide BiopharmaLatest Information Update: 18 Jan 2024
At a glance
- Originator SmartNuclide Biopharma
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 18 Sep 2023 Preclinical trials in Solid tumours in China (unspecified route)